Porphyromonas gingivalis in Alzheimer’s disease brains: Evidence for disease causation and treatment with small-molecule inhibitors

Journal: Science Advances

Published: 2019-01-01

DOI: 10.1126/sciadv.aau3333

Affiliations: 17

Authors: 26

Go to article
Institutions FC
Cortexyme, Inc., United States of America (USA) 0.46
Department of Microbiology, UJ, Poland 0.13
Department of Oral Immunology and Infectious Diseases, UofL, United States of America (USA) 0.06
Centre for Brain Research, The University of Auckland, New Zealand 0.04
Malopolska Centre of Biotechnology (MBC), Poland 0.04
UCSF Department of Orofacial Sciences, United States of America (USA) 0.04
Department of Clinical Science (K2), UIB, Norway 0.04
Bio21 Molecular Science and Biotechnology Institute (Bio21 Institute), UniMelb, Australia 0.04
Oral Health Cooperative Research Centre (CRC), Melbourne Dental School, Australia 0.04
Department of Anatomy and Medical Imaging, The University of Auckland, New Zealand 0.03
Harvard Forsyth Institute, United States of America (USA) 0.02
Harvard School of Dental Medicine (HSDM), United States of America (USA) 0.02
Neurovalida, New Zealand 0.01
Department of Pharmacology, The University of Auckland, New Zealand 0.01
Faculty of Medical and Health Sciences, The University of Auckland, New Zealand 0.01

Return